Prostate Flashcards
(47 cards)
If patient with BPH develops BPE (benign prostatic enlargement), what could develop?
BPE often leads to benign prostatic obstruction (BPO) and bladder outlet obstruction (BOO), which in turn often give lower urinary tract symptoms (LUTS).
Name some symptoms which can occure in lower urinary tract symptoms (LUTS)?
LUTS can be subdivided into symptoms of:
- Urinary storage (eg, urgency, frequency, nocturia, etc),
- Urinary voiding (eg, straining to void, urinary
intermittency, dysuria, hesitancy, etc) - Post-voiding symptoms (eg, sensation of incomplete
bladder emptying, post-void urinary dribbling, etc).
Is BPH a risk factor for prostate cancer?
BPH is not a risk factor for prostate cancer.
Why:
What are possible complications of BPH?
Urinary retention, which increase the risk for UTI, stones, renal damage and bladder diverticuli.
How do you define polyuria?
24-hour urine volume that exceeds 3 liters per day (or 40 mL per kg)
How do you define oliguria?
24h urine <500 ml
How do you define anuria?
24h urine <100 ml
If a patient with BPH have a post-void residual volume of 200 mL, would you be concerned?
In gernal, no!
Normal men have less than 12 mL of residual urine, but most urologists are not concerned unless the PVR volume is greater than 250 mL.
Do you need prostate imaging to diagnose BPH?
No. This is only needed if:
- It is indicated only when the treatment choice of
LUTS/BPH is dependent on total prostate volume, as
in the use of 5ARIs, or in the choice of certain surgical
techniques - This is done when there is suspected prostate cancer,
such as elevated PSA levels, abnormal rectal digital
examination.
What is often the first line pharmacological treatment of BPH?
Alpha-1-adrenergic antagonists.
Why is it important to slow increase the dose in Alpha-1-adrenergic antagonists?
Reduce orthostatic effects
When should patient take alpha-1-adrenergic antagonists?
Once daily at bed time.
When can patient start to feel improvment with alpha-1-adrenergic antagonists?
Can take up to 4-6 weeks
Name alpha-1-adrenergic antagonists, and which of them are uroselective alpha-1-adrenergic antagonists?
Systemic effects (Higer risk of orthostatic effects )
- Terazosin
- Doxazosin,
Uroselective:
- Tamsulosin
- Alfuzosin
- Silodosin
If patient use PDE-5 inhibitors (sildenafil or vardenafil), what type of alpha-1-adrenergic antagonists is best to use?
Uroselective ones (Tamsulosin, alfuzosin or silodosin)
- This is because the systemic ones and PDE-5 intreact
with each other and increase risk of hypotension.
What are common side effects of alpha-1-adrenergic antagonists?
Headache, dizziness, and nasal congestion
If patient take Tamsulosin or silodosin, what could be an important side effect to tell these patient if they want to have children?
Ejaculatory dysfunction
What is the mechanism of action of alpha-1-adrenergic antagonists in BPH patients?
Relaxation of the smooth muscle of the bladder neck and the urethra → decreased resistance to urinary outflow → symptomatic improvement
Which hormone have a potent prostatic growth factor? And which drug could prevent this?
Dihydrotestosterone (DHT).
Drug: 5-alpha reductase inbhitiors, stop the conversion of testo to DHT.
How long does it generally take before 5-alpha-reducatase inhibitors have effect on the BPH symptoms?
Treatment for 6 to 12 months is generally needed before prostate size is sufficiently reduced to improve symptoms
Name 5-alpha-reducatase inhibitors and dose for each.
Finasteride - 5mg daily
Dutasteride - 0.5 mg daily
Do you need to titration for 5-alpha-reducatase inhibitors ?
No you do not.
When could Phosphodiesterase-5 inhibitors be a good alternative for BPH?
It is reasonable to consider treatment with PDE-5 inhibitors in patients who have erectile dysfunction and mild or moderate symptoms (IPSS <20) of BPH
When can anticholinergic agents be a good choice in BPH?
Anticholinergic agents are an alternative monotherapy for patients with predominately irritative symptoms (frequency, urgency, and incontinence) related to overactive bladder and without elevated postvoid residuals.